Monitoring of gastric acid suppression in patients with extraesophageal reflux disease

Seckin O. Ulualp, Linda Brodsky

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: Response to acid suppressive therapy varies in patients with extraesophageal esophageal reflux disease (EERD). Inadequate suppression of gastric acid may contribute to the observed differences in the response to the treatment. The aim of this study was to evaluate suppression of gastric acid in EERD patients being treated with acid suppressive therapy. Methods: Charts of patients with EERD who underwent dual channel 24 h esophageal pH monitoring while receiving acid suppressive therapy between January 2002 and June 2004 were reviewed. Suppression of gastric acid was determined based on the number of acid reflux episodes, esophageal acid exposure, and acid clearance time. Results: Twenty patients (12 male, 8 female, age range: 2-19 years) were identified. Esophageal pH monitoring was within normal limits, documenting complete acid suppression in nine patients (45%). Increased numbers of acid reflux episodes were observed in seven patients. In four patients, the number of acid reflux episodes was normal in spite of incomplete acid suppression. However, other abnormal pH monitoring parameters included delayed acid clearance in three patients and increased acid exposure time in three. The majority of patients also showed alkaline reflux. Conclusion: Esophageal pH monitoring documented incomplete acid suppression in this group of infants, children, adolescents and teens with EERD. Monitoring of gastric acid suppression can be useful in guiding the follow-up of EERD patients who receive acid suppressive therapy.

Original languageEnglish (US)
Pages (from-to)1849-1853
Number of pages5
JournalInternational Journal of Pediatric Otorhinolaryngology
Volume71
Issue number12
DOIs
StatePublished - Dec 2007

Fingerprint

Gastric Acid
Acids
Esophageal Diseases
Gastroesophageal Reflux
Esophageal pH Monitoring
Therapeutics

Keywords

  • Acid suppressive therapy
  • Extraesophageal reflux disease
  • Laryngopharyngeal reflux

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine
  • Surgery

Cite this

Monitoring of gastric acid suppression in patients with extraesophageal reflux disease. / Ulualp, Seckin O.; Brodsky, Linda.

In: International Journal of Pediatric Otorhinolaryngology, Vol. 71, No. 12, 12.2007, p. 1849-1853.

Research output: Contribution to journalArticle

@article{9d24c60fa6294882b7a676d3bf28918a,
title = "Monitoring of gastric acid suppression in patients with extraesophageal reflux disease",
abstract = "Objective: Response to acid suppressive therapy varies in patients with extraesophageal esophageal reflux disease (EERD). Inadequate suppression of gastric acid may contribute to the observed differences in the response to the treatment. The aim of this study was to evaluate suppression of gastric acid in EERD patients being treated with acid suppressive therapy. Methods: Charts of patients with EERD who underwent dual channel 24 h esophageal pH monitoring while receiving acid suppressive therapy between January 2002 and June 2004 were reviewed. Suppression of gastric acid was determined based on the number of acid reflux episodes, esophageal acid exposure, and acid clearance time. Results: Twenty patients (12 male, 8 female, age range: 2-19 years) were identified. Esophageal pH monitoring was within normal limits, documenting complete acid suppression in nine patients (45{\%}). Increased numbers of acid reflux episodes were observed in seven patients. In four patients, the number of acid reflux episodes was normal in spite of incomplete acid suppression. However, other abnormal pH monitoring parameters included delayed acid clearance in three patients and increased acid exposure time in three. The majority of patients also showed alkaline reflux. Conclusion: Esophageal pH monitoring documented incomplete acid suppression in this group of infants, children, adolescents and teens with EERD. Monitoring of gastric acid suppression can be useful in guiding the follow-up of EERD patients who receive acid suppressive therapy.",
keywords = "Acid suppressive therapy, Extraesophageal reflux disease, Laryngopharyngeal reflux",
author = "Ulualp, {Seckin O.} and Linda Brodsky",
year = "2007",
month = "12",
doi = "10.1016/j.ijporl.2007.08.008",
language = "English (US)",
volume = "71",
pages = "1849--1853",
journal = "International Journal of Pediatric Otorhinolaryngology",
issn = "0165-5876",
publisher = "Elsevier Ireland Ltd",
number = "12",

}

TY - JOUR

T1 - Monitoring of gastric acid suppression in patients with extraesophageal reflux disease

AU - Ulualp, Seckin O.

AU - Brodsky, Linda

PY - 2007/12

Y1 - 2007/12

N2 - Objective: Response to acid suppressive therapy varies in patients with extraesophageal esophageal reflux disease (EERD). Inadequate suppression of gastric acid may contribute to the observed differences in the response to the treatment. The aim of this study was to evaluate suppression of gastric acid in EERD patients being treated with acid suppressive therapy. Methods: Charts of patients with EERD who underwent dual channel 24 h esophageal pH monitoring while receiving acid suppressive therapy between January 2002 and June 2004 were reviewed. Suppression of gastric acid was determined based on the number of acid reflux episodes, esophageal acid exposure, and acid clearance time. Results: Twenty patients (12 male, 8 female, age range: 2-19 years) were identified. Esophageal pH monitoring was within normal limits, documenting complete acid suppression in nine patients (45%). Increased numbers of acid reflux episodes were observed in seven patients. In four patients, the number of acid reflux episodes was normal in spite of incomplete acid suppression. However, other abnormal pH monitoring parameters included delayed acid clearance in three patients and increased acid exposure time in three. The majority of patients also showed alkaline reflux. Conclusion: Esophageal pH monitoring documented incomplete acid suppression in this group of infants, children, adolescents and teens with EERD. Monitoring of gastric acid suppression can be useful in guiding the follow-up of EERD patients who receive acid suppressive therapy.

AB - Objective: Response to acid suppressive therapy varies in patients with extraesophageal esophageal reflux disease (EERD). Inadequate suppression of gastric acid may contribute to the observed differences in the response to the treatment. The aim of this study was to evaluate suppression of gastric acid in EERD patients being treated with acid suppressive therapy. Methods: Charts of patients with EERD who underwent dual channel 24 h esophageal pH monitoring while receiving acid suppressive therapy between January 2002 and June 2004 were reviewed. Suppression of gastric acid was determined based on the number of acid reflux episodes, esophageal acid exposure, and acid clearance time. Results: Twenty patients (12 male, 8 female, age range: 2-19 years) were identified. Esophageal pH monitoring was within normal limits, documenting complete acid suppression in nine patients (45%). Increased numbers of acid reflux episodes were observed in seven patients. In four patients, the number of acid reflux episodes was normal in spite of incomplete acid suppression. However, other abnormal pH monitoring parameters included delayed acid clearance in three patients and increased acid exposure time in three. The majority of patients also showed alkaline reflux. Conclusion: Esophageal pH monitoring documented incomplete acid suppression in this group of infants, children, adolescents and teens with EERD. Monitoring of gastric acid suppression can be useful in guiding the follow-up of EERD patients who receive acid suppressive therapy.

KW - Acid suppressive therapy

KW - Extraesophageal reflux disease

KW - Laryngopharyngeal reflux

UR - http://www.scopus.com/inward/record.url?scp=35548977139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35548977139&partnerID=8YFLogxK

U2 - 10.1016/j.ijporl.2007.08.008

DO - 10.1016/j.ijporl.2007.08.008

M3 - Article

C2 - 17889942

AN - SCOPUS:35548977139

VL - 71

SP - 1849

EP - 1853

JO - International Journal of Pediatric Otorhinolaryngology

JF - International Journal of Pediatric Otorhinolaryngology

SN - 0165-5876

IS - 12

ER -